The Recall Desk
ModerateFDA (Devices)·Z-1448-2015·Announced 2015-04-22

Vitrolife Recalls SpermMAR IgA Test Kits Due to Sperm Motility Reduction

Vitrolife Inc is recalling 45 kits of SpermMAR IgA test because a new formulation reduces sperm cell motility in certain samples.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a functional defect (reduced motility) without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary recall.

Plain-English summary

Vitrolife Inc is recalling 45 kits of SpermMAR IgA test kits, specifically lots FP14A09, FP14A10, and FP14A11. The recall is due to a new formulation in the bead solution that causes the motility of sperm cells to reduce in certain samples when the solution is added.

The affected products were distributed in the United States to the state of Oregon and internationally to Argentina. The kits are intended for in vitro diagnostic use.

Consumers and healthcare providers should stop using the affected kits and contact Vitrolife Inc for further instructions or a replacement.

The recalled product

Product
SpermMar Test 0.7ml Beads Particles Label on bottle: SpermMar Test IgA 0.7ml Beads/Particles-50 Tests IND REF SPMA_S LOT Expiration DO NOT FREEZE/NE PAS CONGELER FertiPro N.V. Label on box: SpermMar Test IGA 50 Determination Test Kit CONTENTS 1 vial SpermM
Manufacturer
Vitrolife Inc
Affected units
45

Distribution

Distributed in 1 state: